Our History & Our Future

How Prolytix Became the Protein Chemistry Experts

Founded in 1987 by Kenneth Mann, Ph.D., a prominent scientist in the fields of thrombosis and hemostasis, Prolytix (formerly Haematologic Technologies) quickly developed a reputation as a go-to research reagents company. With expertise in coagulation and hemostasis, we continue to provide highly purified plasma proteins and antibodies to research labs around the world.

From Reagents to Analytical and Bioanalytical Services

Recognizing our extensive protein chemistry expertise, biotech companies, pharmaceutical companies, and CROs turned to Haematologic Technologies for method validation and other analytical and bioanalytical services. The company expanded organically, adding GMP/GCLP CLIA-certified facilities in 2011. In 2020, the company added a high-resolution mass spectrometry (HRMS) lab.

We remain a premier solution for integrated large molecule analytical and bioanalytical services, method and process development, and research reagents, custom tubes, and other collection devices. In early 2022, we became Prolytix to reflect our wide expertise in protein chemistry and analytical services.

Innovative Solutions for Groundbreaking Products

With our roster of protein science experts and proactive approach, we identify and solve complex issues that other CROs cannot. Using high-resolution mass spectrometry (HRMS) and other advanced techniques, Prolytix helps advance large molecule therapies from early development through commercial GMP release.